GlaxoSmithKline to Use RFID Tags to track Triziver March 24, 2006
GlaxoSmithKline, a pharmaceutical firm based in Philadelphia, said last Wednesday that it shall use the RFID tags to prevent the rise of counterfeit HIV drugs called Triziver.
The RFID tag shall be placed in every bottle of Triziver to facilitate identification of the origin of the drug. Through RFID tags, GlaxoSmithKline shall ensure that the drug is properly distributed in the US.
National Association of Boards Pharmacy identifies Triziver as one of the most commonly counterfeited drugs in the US, along with other 31 drugs.
Just recently, US President George Bush singed into law the Stop Counterfeiting In Manufactured Goods Act. Immediately after the approval of the Act, Food and Drug Administration requested all pharmaceutical companies to start employing RFID tags to track drugs and thus, prevent the rise of medication counterfeiting.
Presently, GlaxoSmithKline is working with IBM that shall develop the RFID tags to be used in the said HIV drug.
- Posted in : RFID News
- Author : RFID Editor
Add to: del.icio.us | Digg | Newsvine | Blinklist | Furl | Reddit | Yahoo! MyWeb
Comments»
no comments yet - be the first?